FDA Inspection 1292782 — Carnegie Pharmaceuticals, LLC
The FDA completed an inspection of Carnegie Pharmaceuticals, LLC on October 31, 2025 in Delran, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 31, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Delran, NJ (United States)